Clinical value of positive CNVs results by NIPT without fetal ultrasonography‐identified structural anomalies
Authors:
Open Access
- 18 January 2024
- journal article
- research article
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 12 (1) , e2352
Abstract
Objective: To evaluate the clinical value of positive copy number variations (CNVs) results by non‐invasive prenatal testing (NIPT) without fetal ultrasonography‐identified structural anomalies, especially with several known CNVs results.Methods: A total of 135,981 results of NIPT performed between April 1, 2017, and March 31, 2020, enrolled in the free NIPT service program implemented by the local government were retrospectively analyzed. Of these, 87 cases with positive NIPT screens for CNVs and no fetal ultrasonography‐identified anomalies were recalled and provided genetic counseling. After obtaining full informed consent, these cases were provided invasive prenatal diagnosis by karyotyping and chromosomal microarray analysis (CMA)/copy number variation sequencing (CNV‐seq) with follow‐up. One case was lost, while 86 cases were successfully followed up.Results: A total of 44 (50.6%) cases underwent invasive prenatal diagnosis, of which six cases were detected with abnormal karyotype. CMA/CNV‐Seq revealed 11 fetuses with positive results for CNVs, among whom eight were consistent with NIPT results, two were partially consistent, one was inconsistent, and positive predictive value (PPV) was 22.7% (10/44). For known CNVs, PPVs were 20% (15q11.2‐q13 microdeletion) and 33.3% (5p end deletions). Among 11 pregnant women with positive prenatal diagnosis, seven were confirmed to have pathogenic CNVs in their fetuses; four had CNVs of unknown clinical significance.Conclusions: Even in pregnancies without ultrasonography‐identified anomalies, a positive NIPT screen for CNVs must be interpreted with caution and validated by additional diagnostic study.Keywords
This publication has 18 references indexed in Scilit:
- Clinical experience of laboratory follow‐up with noninvasive prenatal testing using cell‐free DNA and positive microdeletion results in 349 casesPrenatal Diagnosis, 2018
- Noninvasive prenatal screening or advanced diagnostic testing: caveat emptorAmerican Journal of Obstetrics and Gynecology, 2016
- Low-pass whole-genome sequencing in clinical cytogenetics: a validated approachGenetics in Medicine, 2016
- Current Status of Testing for Microdeletion Syndromes and Rare Autosomal Trisomies Using Cell-Free DNA TechnologyObstetrics & Gynecology, 2015
- Prevalence of recurrent pathogenic microdeletions and microduplications in over 9500 pregnanciesPrenatal Diagnosis, 2015
- Cell-free DNA Analysis for Noninvasive Examination of TrisomyNew England Journal of Medicine, 2015
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- A method for noninvasive detection of fetal large deletions/duplications by low coverage massively parallel sequencingPrenatal Diagnosis, 2013
- Chromosomal Microarray versus Karyotyping for Prenatal DiagnosisNew England Journal of Medicine, 2012
- Cri du Chat syndromeOrphanet Journal of Rare Diseases, 2006